Jia Sun, Ph.D.
Analyst
Bio
Jia Sun, Ph.D.is an Analyst on the Public Equity team and joined OrbiMed in 2022. Prior to joining OrbiMed, he was a Biotech Analyst in public and private equities at Verition Fund Management. Previously, Jia was a Venture Investor at 6 Dimensions Capital in Boston focusing on early-stage biotech investment. Before transitioning to investing, he was an Engagement Manager with McKinsey & Company in Los Angeles. Jia holds a Ph.D. in Chemical Biology and an MA in Statistics from The University of Michigan, Ann Arbor.
